Suppr超能文献

普遍的术前 SARS-CoV-2 检测有助于在当地 COVID-19 疫情高峰期安全地进行手术治疗。

Universal preoperative SARS-CoV-2 testing can facilitate safe surgical treatment during local COVID-19 surges.

机构信息

Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Palantir Technologies, Palo Alto, California, USA.

出版信息

Br J Surg. 2021 Jan 27;108(1):e24-e26. doi: 10.1093/bjs/znaa062.

Abstract

This research letter details the experience of a large cancer center's experience with a universal asymptomatic preoperative SARS-CoV-2 testing program that facilitated safe surgical treatment during a local surge of coronavirus cases. A total of 5,234 asymptomatic tests were performed with a test positivity rate that correlated with the increase in community prevalence of COVID-19 infections. No patients developed a postoperative SARS-CoV-2 infection with no documented patient-to-patient or patient-to-provider spread.

摘要

这封研究信函详细介绍了一家大型癌症中心在当地冠状病毒病例激增期间实施通用无症状术前 SARS-CoV-2 检测计划的经验。共进行了 5234 例无症状检测,检测阳性率与社区 COVID-19 感染流行率的增加相关。没有患者发生术后 SARS-CoV-2 感染,也没有记录到患者之间或患者与医务人员之间的传播。

相似文献

10
SARS-CoV-2 transmission without symptoms.新型冠状病毒2(SARS-CoV-2)无症状传播。
Science. 2021 Mar 19;371(6535):1206-1207. doi: 10.1126/science.abf9569.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验